We focus where we have deep operating experience: companies where science, technology and regulation meet, and the investors who back them.
Life Sciences
Life sciences markets reward evidence, not hype. Sales cycles are long, buyers are scientists, clinicians and lab directors, and every claim is regulated. We help diagnostics, medical device and biotech companies build repeatable adoption: a data-backed value proposition, reference customers, the right channels in each region, a regulatory strategy that supports the commercial plan, and AI-enabled marketing and sales.
Genomics
Genomics moves fast. Technology keeps changing, interpretation has become the bottleneck, and the market is shifting from research into routine clinical care. We help genomics software, sequencing and testing companies cross into clinical markets, integrate into lab workflows, plan for IVDR, CLIA and data privacy requirements, and build AI-enabled sales engines that find and win the labs adopting sequencing.
Private Equity
We work with investors from due diligence to exit. We assess market reality, competitive position, customer quality, regulatory risk and team depth before you invest. After the deal, we help management execute the value creation plan, serve as independent board advisors, and provide continued coaching and support until the plan becomes results.